Our ***** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Q2 revenue growth of 53% was primarily driven by durable yield improvements resulting from clinically targeted enrollment campaigns and member-to-member referrals.
Management is pivoting from a pure musculoskeletal (MSK) focus to a broader care automation platform, leveraging reusable technology components to scale across new clinical indications.
The acquisition of Cylinder Health for $105 million accelerates the entry into gastrointestinal (GI) health by an estimated 18-24 months, providing immediate access to established PBM and health plan partnerships.
Operating margin expanded by 1,000 basis points year-over-year to 29%, reflecting significant operating leverage and care team efficiency gains through AI and automation.
#Health
Q2 revenue growth of 53% was primarily driven by durable yield improvements resulting from clinically targeted enrollment campaigns and member-to-member referrals.
Management is pivoting from a pure musculoskeletal (MSK) focus to a broader care automation platform, leveraging reusable technology components to scale across new clinical indications.
The acquisition of Cylinder Health for $105 million accelerates the entry into gastrointestinal (GI) health by an estimated 18-24 months, providing immediate access to established PBM and health plan partnerships.
Operating margin expanded by 1,000 basis points year-over-year to 29%, reflecting significant operating leverage and care team efficiency gains through AI and automation.
#Health
5 days ago
